Pulmonary Cancer Clinical Trial
Official title:
Multidisciplinary Rehabilitation After Cancer Pulmonis Operation - a Randomized Controlled Trial
The purpose of this investigation is to determine the effects of exercise training on quality of life and physical capacity, 3 months and 1 year after radical operation for pulmonary cancer.
Patients who are radically operated for pulmonary cancer report suffering from respiratory
problems, mostly dyspnoea, 5 years after operation. Dyspnoea restricts their physical
capability and leads to poorer physical, social and mental wellbeing. The effects of
training programs on physical and mental wellbeing for cancer patients are well documented.
Most of the studies are though performed on patients suffering from breast, colon and
prostate cancer. There are only few studies addressing patients with pulmonary cancer. They
are mostly focused on short term effects of exercise training on quality of life, with no
control group included in the trials. These studies target patients after different forms
for treatment, including surgery, chemotherapy and radiation. There is no data referring to
quality of life of patients who are radically operated for pulmonary cancer.
Comparison: multidisciplinary group intervention consisting of exercise training and
dyspnoea counseling, 10 times, once a week, compared with one instruction in exercise
training and dyspnoea counseling. Exercise training is given by a physiotherapist. Both
groups receive in addition standard treatment, which is up to 3 counseling sessions with a
nurse.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03144622 -
18F-FSPG PET/CT Imaging in Patients With Cancers
|
||
Completed |
NCT01860898 -
A Phase I Study of iPS Cell Generation From Patients With COPD
|
N/A | |
Completed |
NCT02476526 -
Safety of Low Dose IV Contrast CT Scanning in Chronic Kidney Disease
|
Phase 4 | |
Completed |
NCT00098085 -
Study of the Feasibility to Derive Vaccine From Tumor Tissue in Patients With Non-Small Cell Lung Cancer
|
Phase 2 | |
Completed |
NCT05011890 -
Remote Monitoring of Lung Cancer Patient-Reported Outcomes Using Moovcare®
|
N/A | |
Completed |
NCT02616211 -
An Integrated Approach to Treating Recurrent Thoracic Carcinomas Resistant to Tyrosine Kinase Inhibitors
|
||
Completed |
NCT03293433 -
Quantification of microRNAs in Diagnosis of Pulmonary Nodules
|
||
Recruiting |
NCT05545085 -
Thoracoscopic Laser Speckle Contrast Imaging for Segment Resections
|
||
Enrolling by invitation |
NCT06102369 -
The Role of Narrow Band Imaging (NBI) Bronchoscopy in Detecting Bronchial Squamous Dysplasia in Lung Cancer
|
||
Completed |
NCT00344773 -
First-line Treatment for Adenocarcinoma Patients With Epidermal Growth Factor Receptor (EGFR) Mutation
|
Phase 2 | |
Not yet recruiting |
NCT05781581 -
A Retrospective Cohort Study for Main Postoperative Complications After SARS-CoV-2 Infection
|
||
Terminated |
NCT02673021 -
MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s)
|
N/A | |
Not yet recruiting |
NCT05857995 -
Precision Lung Cancer Survivorship Care Intervention
|
N/A | |
Recruiting |
NCT05521789 -
Erector Spinae Block for Thoracic Surgery
|
Phase 4 | |
Recruiting |
NCT04699188 -
Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation
|
Phase 1/Phase 2 | |
Recruiting |
NCT05977803 -
Contribution of the CEST Sequence in the Characterization of Radionecrosis of Brain Metastases of Pulmonary Origin
|
N/A | |
Not yet recruiting |
NCT05694949 -
Main Postoperative Complications After COVID-19
|
||
Completed |
NCT05915221 -
Effect of SMS Use on Postoperative Respiratory and Cough Exercise Compliance
|
N/A | |
Active, not recruiting |
NCT04740047 -
Cios Mobile 3D Spin for Robotic Bronchoscopy
|
||
Completed |
NCT02410603 -
Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer
|